DETAILS, FICTION AND MBL77

mutations specified The reality that, as stated beneath, CLL therapy is based on the existence or absence of those mutations. The existing consensus is the fact, apart from clonal mutations, subclonal mutations that has a variant allelic frequency ranging from five to ten% (and so beneath the brink of detection by traditional molecular techniques)